Karin L. Bengtsson-Lovgren
Uppsala, C, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Safety of Matrix-M-adjuvanted COVID-19, seasonal influenza, combination influenza-COVID-19, and malaria vaccines: a review of the evidence.
Journal: Expert review of vaccines
Published: March 12, 2026
Matrix-M adjuvant triggers inflammasome activation and enables antigen cross-presentation through induction of lysosomal membrane permeabilization.
Journal: NPJ vaccines
Published: April 30, 2025
Evaluation of a novel malaria anti-sporozoite vaccine candidate, R21 in Matrix-M adjuvant, in the UK and Burkina Faso: two phase 1, first-in-human trials.
Journal: The Lancet. Microbe
Published: October 05, 2023
A randomized first-in-human phase I trial of differentially adjuvanted Pfs48/45 malaria vaccines in Burkinabé adults.
Journal: The Journal of clinical investigation
Published: September 11, 2023
The Matrix-M™ adjuvant: A critical component of vaccines for the 21st century.
Journal: Human vaccines & immunotherapeutics
Published: April 28, 2023
Immunogenicity of a recombinant hemagglutinin neuraminidase-Porcine rubulavirus produced by Escherichia coli of Porcine rubulavirus gives protective immunity of litter after challenge.
Journal: The Journal of veterinary medical science
Published: October 23, 2022
Innate immune responses induced by the saponin adjuvant Matrix-M in specific pathogen free pigs.
Journal: Veterinary research
Published: January 16, 2017
Matrix-M™ adjuvation broadens protection induced by seasonal trivalent virosomal influenza vaccine.
Journal: Virology journal
Published: July 28, 2015
Purification, stability, and immunogenicity analyses of five bluetongue virus proteins for use in development of a subunit vaccine that allows differentiation of infected from vaccinated animals.
Journal: Clinical and vaccine immunology : CVI
Published: January 24, 2014
Evaluation of the immunogenicity of an experimental subunit vaccine that allows differentiation between infected and vaccinated animals against bluetongue virus serotype 8 in cattle.
Journal: Clinical and vaccine immunology : CVI
Published: May 31, 2013
Last Updated: 09/26/2026